These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1822246)

  • 1. Antisense mapping of the c-fos promoter: role of the serum response element.
    Robinson-Benion C; Kamata N; Holt JT
    Antisense Res Dev; 1991; 1(1):21-33. PubMed ID: 1822246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic helix-loop-helix proteins can act at the E-box within the serum response element of the c-fos promoter to influence hormone-induced promoter activation in Sertoli cells.
    Chaudhary J; Skinner MK
    Mol Endocrinol; 1999 May; 13(5):774-86. PubMed ID: 10319327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense promoter mapping. Inhibitory methods of transcriptional analysis.
    Holt JT
    Ann N Y Acad Sci; 1992 Oct; 660():88-94. PubMed ID: 1340160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net-b, a Ras-insensitive factor that forms ternary complexes with serum response factor on the serum response element of the fos promoter.
    Giovane A; Sobieszczuk P; Ayadi A; Maira SM; Wasylyk B
    Mol Cell Biol; 1997 Oct; 17(10):5667-78. PubMed ID: 9315625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-fos induction by stress can be mediated by the SRE.
    van Delft S; Coffer P; Kruijer W; van Wijk R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):542-8. PubMed ID: 8267588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type specific multiprotein complex formation over the c-fos serum response element in vivo: ternary complex formation is not required for the induction of c-fos.
    König H
    Nucleic Acids Res; 1991 Jul; 19(13):3607-11. PubMed ID: 1906604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-fos expression by transforming Ha-ras in HC11 mouse mammary epithelial cells is PKC-dependent and mediated by the serum response element.
    Uberall F; Kampfer S; Doppler W; Grunicke HH
    Cell Signal; 1994 Mar; 6(3):285-97. PubMed ID: 7917786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense rescue defines specialized and generalized functional domains for c-Fos protein.
    Holt JT
    Mol Cell Biol; 1993 Jun; 13(6):3821-30. PubMed ID: 8497282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum response element and an AP-1/ATF sequence immediately downstream co-operate in the regulation of c-fos transcription.
    Morgan IM; Birnie GD
    Cell Prolif; 1992 May; 25(3):205-15. PubMed ID: 1596533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter.
    Lazo PS; Dorfman K; Noguchi T; Mattéi MG; Bravo R
    Nucleic Acids Res; 1992 Jan; 20(2):343-50. PubMed ID: 1741260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of c-fos promoter by MyoD on muscle cell differentiation.
    Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
    Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myogenin binds to and represses c-fos promoter.
    Trouche D; Masutani H; Groisman R; Robin P; Lenormand JL; Harel-Bellan A
    FEBS Lett; 1995 Mar; 361(2-3):140-4. PubMed ID: 7698311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites.
    Seternes OM; Sørensen R; Johansen B; Loennechen T; Aarbakke J; Moens U
    Biochim Biophys Acta; 1998 Feb; 1395(3):345-60. PubMed ID: 9512670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of human c-fos expression by the retinoblastoma gene product.
    Robbins PD; Horowitz JM; Mulligan RC
    Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements.
    Avantaggiati ML; Natoli G; Balsano C; Chirillo P; Artini M; De Marzio E; Collepardo D; Levrero M
    Oncogene; 1993 Jun; 8(6):1567-74. PubMed ID: 8502480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of an estradiol response region in the mouse c-fos oncogene.
    Hyder SM; Stancel GM; Loose-Mitchell DS
    Steroids; 1991 Oct; 56(10):498-504. PubMed ID: 1805451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of transformed phenotypes by antisense fos.
    Bradley MO; Manam S; Kraynak AR; Nichols WW; Ledwith BJ
    Ann N Y Acad Sci; 1992 Oct; 660():124-35. PubMed ID: 1340116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of fos: the dyad symmetry element as the major target of repression.
    König H; Ponta H; Rahmsdorf U; Büscher M; Schönthal A; Rahmsdorf HJ; Herrlich P
    EMBO J; 1989 Sep; 8(9):2559-66. PubMed ID: 2511006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target.
    White CM; Heidenreich O; Nordheim A; Beerman TA
    Biochemistry; 2000 Oct; 39(40):12262-73. PubMed ID: 11015205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.